UNICA IRIS Institutional Research Information System

DEVOTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 146.205
NA - Nord America 6.849
AS - Asia 1.034
SA - Sud America 11
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 154.110
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 144.294
US - Stati Uniti d'America 6.831
CN - Cina 720
UA - Ucraina 626
SE - Svezia 521
DE - Germania 249
GB - Regno Unito 203
SG - Singapore 188
FI - Finlandia 159
FR - Francia 60
IN - India 34
KR - Corea 34
VN - Vietnam 22
NL - Olanda 19
RU - Federazione Russa 19
BE - Belgio 17
CA - Canada 16
CZ - Repubblica Ceca 11
IR - Iran 10
JP - Giappone 10
PL - Polonia 8
BR - Brasile 7
MU - Mauritius 6
PT - Portogallo 5
TR - Turchia 5
AT - Austria 4
EU - Europa 4
HK - Hong Kong 4
BG - Bulgaria 3
AR - Argentina 1
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 154.110
Salva come PNG Salva come JPEG
Città #
Cagliari 139.908
Uta 4.001
Fairfield 898
Woodbridge 711
Chandler 618
Houston 547
Ashburn 499
Ann Arbor 418
Seattle 363
Boardman 339
Nyköping 336
Jacksonville 334
Wilmington 321
Dearborn 291
Cambridge 277
Nanjing 114
Singapore 95
Beijing 89
Shanghai 87
Boston 84
San Diego 80
Santa Clara 71
Helsinki 64
Shenyang 48
Milan 38
Nanchang 35
Seoul 34
Hebei 32
Redwood City 30
Guangzhou 29
Los Angeles 26
Hefei 25
Changsha 22
Dong Ket 22
London 22
Tianjin 22
Verona 22
Washington 22
New York 21
Santa Maria Coghínas 20
Kunming 18
Mountain View 18
Munich 18
Norwalk 18
San Mateo 18
Brussels 17
Orange 17
Pune 17
Jiaxing 16
Jinan 16
Zhengzhou 14
Ningbo 13
Toronto 13
Detroit 12
Leawood 12
Falls Church 11
Auburn Hills 10
Augusta 10
Brno 10
Amsterdam 9
Monmouth Junction 9
San Francisco 8
Sassari 8
Padova 7
Saint Petersburg 7
Ardabil 6
Chengdu 6
Edinburgh 6
Mumbai 6
Oristano 6
Rome 6
Sarroch 6
Taizhou 6
Florence 5
Kilburn 5
Millbury 5
New Bedfont 5
Shenzhen 5
Wuhan 5
Xian 5
Arezzo 4
Hangzhou 4
Hong Kong 4
Nürnberg 4
Phoenix 4
Torino 4
Vienna 4
Alghero 3
Atlanta 3
Bologna 3
Borås 3
Brescia 3
Chicago 3
Frankfurt am Main 3
Fuzhou 3
Siena 3
Sofia 3
Wenzhou 3
Wuxi 3
Ankara 2
Totale 151.490
Salva come PNG Salva come JPEG
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.648
Maternal immune activation disrupts dopamine system in the offspring 3.985
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 3.963
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.591
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.373
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 3.149
null 2.940
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 2.914
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 2.885
Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats 2.765
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.722
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.663
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress 2.624
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.589
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.550
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.505
Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models 2.487
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.470
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.436
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.335
Effects of maternal immune activation on dopamine activity in male and female offspring 2.312
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.215
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson's disease 2.214
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice 2.192
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.174
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease 2.153
Modulation of the Startle Response in REM Sleep Behavior Disorder 2.123
Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats 2.048
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 1.983
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 1.953
null 1.934
The steroid 5-alpha reductases mediate the abnormalities in information processing and attention mechanisms induced by REM sleep deprivation 1.933
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 1.857
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.838
Antipsychotic-like properties of antiandrogenic drugs: focus on dopaminergic system 1.795
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.746
Reserpine treatment ablates the deficits of sensorimotor gating induced by dopamine D3 receptor activation in Sprague-Dawley, but not Long-Evans rats 1.745
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.728
null 1.722
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechyanisms in nucleus accumbens and prefrontal cortex 1.717
5-alpha reductase expression is reduced in brain of isolation-reared rats: relevance to dopaminergic impairments 1.607
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.589
Inhibition of 5α-reductase counters the behavioral effects of D1, but not D2 dopamine receptor activation 1.553
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.518
Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release 1.492
Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex 1.481
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.470
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 1.444
Fasting biases µ-opioid receptors toward β–arrestin2-dependent signaling in the accumbens shell 1.439
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.390
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.381
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.359
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 1.292
The genetic deletion of monoamine oxidase (MAO) gene promotes autistic-like phenotypes in mice 1.291
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex 1.277
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.261
Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex 1.254
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.220
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.212
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.194
Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice 1.113
null 1.078
Steroid 5 alpha-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders 1.016
Thymic oxytocin like immunoreactivity is increased in morphine tolerant dependent rats 933
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 865
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 843
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 795
5-alpha reductase inhibitors as a novel therapy for Tourette Syndrome: Clinical Evidence 750
Detection of 3H-cimetidine specific binding in rat anterior pituitary 718
5-Alpha reductase inhibitors modulate dopaminergic signaling: relevance to psychosis 681
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 638
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 611
Biochemical characterization of rat forebrain septum dopaminergic innervation. 586
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 556
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation 550
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 546
Decreased adenosine A2 receptor function in morphine dependent rats 488
null 470
Effect of calcium antagonists on [3H] dopamine uptake 469
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 462
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 452
Evidence that cortical dopamine is a co-transmitter in noradrenergic neurons 448
Selective adenylate cyclase increase in the limbic area of long term imipramine treated rats 438
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 422
On the origin of cortical dopamine: Is it a co-transmitter in noradrenergic neurons? 402
null 398
Opioid activity of lefetamine 388
null 381
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 378
[3H] spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland 375
Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates 374
Differential effect of Mu, Delta, and kappa opioid agonists on adenylate cyclase activity 357
Adrenergic sensitive adenylate cyclase in rat posterior pituitary 354
Possible antidepressant activity of methadone 350
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 350
Dopamine and noradrenaline coupling in the cerebral cortex 348
Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats 344
Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders 341
In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats 336
Opiate k receptors agonists do not inhibit adenylate cyclase activity 336
Totale 149.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028.118 0 0 0 0 11.886 8.201 4.355 963 608 588 624 893
2020/202141.262 1.241 1.545 1.446 11.887 8.560 4.345 3.194 2.456 874 1.958 2.175 1.581
2021/20228.438 914 581 730 497 582 688 581 540 606 765 906 1.048
2022/202311.543 1.070 1.439 1.147 953 994 1.182 651 811 901 800 1.045 550
2023/202412.011 622 500 464 656 1.148 1.638 1.812 737 753 892 1.228 1.561
2024/202515.361 3.958 4.608 3.873 1.955 967 0 0 0 0 0 0 0
Totale 154.407